Latest news with #Ambiq
Yahoo
15 hours ago
- Business
- Yahoo
Kleiner Perkins-backed Ambiq pops on IPO debut
Ambiq Micro, a 15-year-old manufacturer of energy-efficient chips for wearable and medical devices, closed its first day of trading on Wednesday at $38.53 a share, a 61% increase from the $24 IPO price the company set the previous day. The success of the IPO signals strong investor demand in the public market for new small-cap companies benefiting from AI innovation. Ambiq closed its first day as a public company with a valuation of $656 million (excluding employee options). This represents a significant increase from its last private funding valuation of $450 million in 2023, according to PitchBook. Ambiq has pitched itself as well-positioned to capitalize on the growth driven by AI. 'Because we're so low energy, we can put more intelligence and more AI on board' of edge processors, the company's CTO Scott Hanson told TechCrunch. For the three months that ended March 31, Ambiq posted a net loss of $8.3 million against revenues of $15.7 million, the company's S1 filing shows. The Q1 results mark a slight improvement from the first quarter of 2024, when the company reported a $9.8 million loss on $15.2 million in revenue. Kleiner Perkins and EDB Investments, a Singaporean state-backed entity, are the largest outside backers of Ambiq, according to the filing. Wen Hsieh, who was a general partner at Kleiner Perkins until 2023, first backed Ambiq when the company raised its Series C in 2014. Hsieh also invested in Ambiq after he launched his own venture firm, Matter Venture Partners, two years ago. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
a day ago
- Business
- CNBC
Ambiq CEO: AI product lines are what we'll enable the most
Fumihide Esaka, Ambiq CEO, joins CNBC's 'Money Movers' to discuss the company's trading debut, what its product use cases are, and much more.
Cision Canada
a day ago
- Business
- Cision Canada
NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO
NEW YORK, July 30, 2025 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. delivers the pre-market update on July 30th Equities are little changed early Wednesday after a delayed trade deal with China took the S&P 500 three tenths of a percent from its record. It was the first session of the last seven that the index didn't finish at an all-time high. This afternoon, Americans will receive the Federal Reserve's decision on interest rates. The market is nearly certain rates will remain unchanged despite pressure from the White House to lower them. Chipmaker Ambiq debuts at the NYSE today after raising $96 million in its IPO. Shares priced at $24 in an upsized deal. Ambiq will trade under the ticker symbol AMBQ.
Barnama
a day ago
- Business
- Barnama
Ambiq Prices US$96 Mln IPO, Set To Debut On NYSE As 'AMBQ'
KUALA LUMPUR, July 30 (Bernama) -- Ambiq Micro Inc (Ambiq) has announced the pricing of its upsized initial public offering (IPO) at US$24 per share, raising US$96 million before expenses. (US$1=RM4.23) According to the statement, the Austin-based company is offering four million shares, with a 30-day option for underwriters to purchase 600,000 more to cover over-allotments. The shares are expected to begin trading on the New York Stock Exchange under the ticker 'AMBQ' on July 30, with the offering expected to close the next day, pending customary approvals.
Yahoo
2 days ago
- Business
- Yahoo
Ambiq Announces Pricing of Upsized Initial Public Offering
AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) -- Ambiq Micro, Inc. ('Ambiq'), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common stock at a public offering price of $24.00 per share. The gross proceeds to Ambiq from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Ambiq, are expected to be $96.0 million. In addition, Ambiq has granted the underwriters a 30-day option to purchase up to an additional 600,000 shares (solely to cover over-allotments, if any) of its common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol 'AMBQ' on July 30, 2025, and the offering is expected to close on July 31, 2025, subject to the satisfaction of customary closing conditions. BofA Securities and UBS Investment Bank are acting as joint lead book-running managers for the offering. Needham & Company and Stifel are acting as joint book-running managers for the offering. A registration statement relating to the offering of securities was declared effective by the U.S. Securities and Exchange Commission on July 29, 2025. The offering is being made only by means of a prospectus. When available, copies of the final prospectus relating to the offering may be obtained by contacting: BofA Securities, NC1-022-02-25, 201 North Tryon Street, Charlotte, North Carolina 28255-0001, Attention: Prospectus Department, or by email at or UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, New York 10019, by telephone at (888) 827-7275 or by emailing ol-prospectus-request@ This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Ambiq Ambiq's mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. Ambiq enables its customers to deliver AI compute at the edge where power consumption challenges are the most severe. Ambiq's technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT®), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. Ambiq has powered over 270 million devices to date. Forward-Looking Statements The statements contained in this press release that are not historical facts are forward-looking statements. You can identify forward-looking statements because they contain words such as 'believes,' 'expects,' 'may,' 'will,' 'should,' 'seeks,' 'intends,' 'plans,' 'estimates,' or 'anticipates,' or similar expressions which concern our strategy, plans, projections or intentions. These forward-looking statements may be included throughout this press release, and include, but are not limited to, statements relating to Ambiq's expected gross proceeds from the initial public offering, the expected date for Ambiq common stock to begin trading on the New York Stock Exchange and the expected closing of the initial public offering. By their nature, forward-looking statements are not statements of historical fact or guarantees of future performance and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Ambiq's expectations, beliefs and projections are expressed in good faith and Ambiq believes there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this release. Ambiq undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. Contact Charlene Wan VP of Corporate Marketing and Investor Relationscwan@ A photo accompanying this announcement is available at in to access your portfolio
